Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 380 | 379 | 379 | 379 | 380 |
| Gross Profit | 380 | 379 | 379 | 379 | 380 |
| Operating Expenses | 14,585 | 13,528 | 15,753 | 15,190 | 19,713 |
| Operating Income | -14,205 | -13,149 | -15,374 | -14,811 | -19,333 |
| Other Income | 205 | 320 | 458 | 509 | 496 |
| Pre-tax Income | -14,000 | -12,829 | -14,916 | -14,302 | -18,837 |
| Net Income Continuous | -14,000 | -12,829 | -14,916 | -14,302 | -18,837 |
| Net Income | $-14,000 | $-12,829 | $-14,916 | $-14,302 | $-18,837 |
| EPS Basic Total Ops | -0.43 | -0.41 | -0.47 | -0.53 | -0.71 |
| EPS Basic Continuous Ops | -0.43 | -0.41 | -0.47 | -0.53 | -0.70 |
| EPS Diluted Total Ops | -0.43 | -0.41 | -0.47 | -0.53 | -0.71 |
| EPS Diluted Continuous Ops | -0.43 | -0.41 | -0.47 | -0.53 | -0.70 |
| EBITDA(a) | $-14,313 | $-13,325 | $-15,598 | $-14,991 | $-19,531 |